GoodRx Holdings annual depreciation and amortization
2018
2019
2020
2021
2022
2023
2024
2025
GoodRx Holdings Depreciation & Amortization Growth & History (GDRX)
GoodRx Holdings's depreciation and amortization was $85.2M for fiscal 2025.
View full GoodRx Holdings company overviewGoodRx Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $85.2M | $15.7M | +22.55% |
| 2024 | 2024-12-31 | $69.5M | −$38.1M | −35.41% |
| 2023 | 2023-12-31 | $107.7M | $53.5M | +98.73% |
| 2022 | 2022-12-31 | $54.2M | $19.6M | +56.86% |
| 2021 | 2021-12-31 | $34.5M | $16.1M | +87.41% |
| 2020 | 2020-12-31 | $18.4M | $4.9M | +35.78% |
| 2019 | 2019-12-31 | $13.6M | $3.8M | +38.42% |
| 2018 | 2018-12-31 | $9.8M | — | — |
GoodRx Holdings quarterly depreciation and amortization
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $22.3M | $2.5M | +12.87% |
| Q1 2026 | 2026-03-31 | $21.8M | $880,000 | +4.21% |
| Q4 2025 | 2025-12-31 | $23.1M | — | — |
| Q3 2025 | 2025-09-30 | $21.4M | $3.9M | +22.22% |
| Q2 2025 | 2025-06-30 | $19.7M | $2.8M | +16.29% |
| Q1 2025 | 2025-03-31 | $20.9M | $5.0M | +31.18% |
| Q3 2024 | 2024-09-30 | $17.5M | −$15.5M | −46.90% |
| Q2 2024 | 2024-06-30 | $17.0M | $868,000 | +5.39% |
| Q1 2024 | 2024-03-31 | $15.9M | $1.0M | +6.71% |
| Q3 2023 | 2023-09-30 | $33.0M | $19.1M | +136.70% |
| Q2 2023 | 2023-06-30 | $16.1M | $2.8M | +20.86% |
| Q1 2023 | 2023-03-31 | $14.9M | $3.6M | +31.35% |
| Q3 2022 | 2022-09-30 | $14.0M | $3.8M | +37.31% |
| Q2 2022 | 2022-06-30 | $13.3M | $5.0M | +59.15% |
| Q1 2022 | 2022-03-31 | $11.4M | $6.0M | +112.14% |
| Q3 2021 | 2021-09-30 | $10.2M | $5.0M | +96.92% |
| Q2 2021 | 2021-06-30 | $8.4M | $3.8M | +85.11% |
| Q1 2021 | 2021-03-31 | $5.4M | $1.0M | +23.38% |
| Q3 2020 | 2020-09-30 | $5.2M | $1.6M | +42.98% |
| Q2 2020 | 2020-06-30 | $4.5M | — | — |
| Q1 2020 | 2020-03-31 | $4.3M | — | — |
| Q3 2019 | 2019-09-30 | $3.6M | — | — |
GoodRx Holdings depreciation and amortization trends
Over the last five fiscal years, GoodRx Holdings's depreciation and amortization increased from $18.4M to $85.2M, a change of $66.8M. The latest reported quarter, Q2 2026, shows $22.3M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GoodRx Holdings source filings ↗